Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stamp

Showing results (171-180 of 323) with videos related to

Pageof 33
Sort By:
Frontiers in Genetics|November 4, 2015
Association of SLC2A9 genotype with phenotypic variability of serum urate in pre-menopausal womenRuth K Topless, Tanya J Flynn, Murray Cadzow, et al.
Therapeutic Drug Monitoring|July 30, 2015
Development of an ELISA-Based Competitive Binding Assay for the Analysis of Drug Concentration and Antidrug Antibody Levels in Patients Receiving Adalimumab or InfliximabBarry D Hock, Lisa K Stamp, Matthew W Hayman, et al.
ACR Open Rheumatology|April 15, 2021
Gout, Rheumatoid Arthritis, and the Risk of Death Related to Coronavirus Disease 2019: An Analysis of the UK BiobankRuth K Topless, Amanda Phipps-Green, Megan Leask, et al.
Arthritis Research & Therapy|November 18, 2018
How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based doseLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Rheumatology Advances in Practice|February 1, 2021
Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature reviewHamish Farquhar, Ana B Vargas-Santos, Huai Leng Pisaniello, et al.
Annals of the Rheumatic Diseases|March 19, 2017
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with goutLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Rheumatology International|September 28, 2015
Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and goutTahzeeb Fatima, Sara Altaf, Amanda Phipps-Green, et al.
Clinical Pharmacokinetics|September 11, 2014
Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritisShan Pan, Lisa K Stamp, Stephen B Duffull, et al.
Frontiers in Genetics|May 16, 2018
Multiplexed Nanopore Sequencing of HLA-B Locus in Māori and Pacific Island SamplesKim N T Ton, Simone L Cree, Sabine J Gronert-Sum, et al.
The Journal of Rheumatology|August 1, 2024
Analysis of Gout Remission Definitions in a Randomized Controlled Trial of Colchicine Prophylaxis for People With Gout Initiating AllopurinolAdwoa Dansoa Tabi-Amponsah, Lisa K Stamp, Anne Horne, et al.
Pageof 33

Showing results (171-180 of 323) with videos related to

Sort By:
Pageof 33
Frontiers in Genetics|November 4, 2015
Association of SLC2A9 genotype with phenotypic variability of serum urate in pre-menopausal womenRuth K Topless, Tanya J Flynn, Murray Cadzow, et al.
Therapeutic Drug Monitoring|July 30, 2015
Development of an ELISA-Based Competitive Binding Assay for the Analysis of Drug Concentration and Antidrug Antibody Levels in Patients Receiving Adalimumab or InfliximabBarry D Hock, Lisa K Stamp, Matthew W Hayman, et al.
ACR Open Rheumatology|April 15, 2021
Gout, Rheumatoid Arthritis, and the Risk of Death Related to Coronavirus Disease 2019: An Analysis of the UK BiobankRuth K Topless, Amanda Phipps-Green, Megan Leask, et al.
Arthritis Research & Therapy|November 18, 2018
How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based doseLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Rheumatology Advances in Practice|February 1, 2021
Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature reviewHamish Farquhar, Ana B Vargas-Santos, Huai Leng Pisaniello, et al.
Annals of the Rheumatic Diseases|March 19, 2017
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with goutLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Rheumatology International|September 28, 2015
Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and goutTahzeeb Fatima, Sara Altaf, Amanda Phipps-Green, et al.
Clinical Pharmacokinetics|September 11, 2014
Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritisShan Pan, Lisa K Stamp, Stephen B Duffull, et al.
Frontiers in Genetics|May 16, 2018
Multiplexed Nanopore Sequencing of HLA-B Locus in Māori and Pacific Island SamplesKim N T Ton, Simone L Cree, Sabine J Gronert-Sum, et al.
The Journal of Rheumatology|August 1, 2024
Analysis of Gout Remission Definitions in a Randomized Controlled Trial of Colchicine Prophylaxis for People With Gout Initiating AllopurinolAdwoa Dansoa Tabi-Amponsah, Lisa K Stamp, Anne Horne, et al.
Pageof 33